Keyphrases
Adalimumab
23%
Adult Humans
14%
American College of Rheumatology
29%
Ankylosing Spondylitis
23%
Anti-neutrophil Antibody
14%
Antipneumococcal
14%
Arthritis Patients
30%
Autoimmune Inflammatory Rheumatic Disease
14%
Bisphosphonates
29%
Calcium Pyrophosphate Deposition
28%
Calcium Pyrophosphate Deposition Disease
49%
Care Gap
14%
Cartilage
21%
Cellular Immune Response
14%
Classification Criteria
29%
Complete Lists
14%
Disease Activity
31%
Enthesitis
21%
Ethyl
44%
European League against Rheumatism (EULAR)
48%
Familial Mediterranean Fever
14%
H1N1 Virus
14%
Healthy Controls
35%
Human Chondrocytes
20%
Immunogenicity
46%
Inflammatory Bowel Disease
18%
Latent Tuberculosis Infection
14%
Methotrexate
42%
Methoxy
59%
NPP1
29%
Nucleotide Pyrophosphatase
22%
Nucleotide Pyrophosphatase/phosphodiesterase
29%
Osteoarthritis
34%
Osteoarthritis Chondrocyte
29%
Pathologic
14%
Peritonitis
14%
Phosphodiesterase
29%
Psoriatic Arthritis
100%
Quantiferon TB Gold
14%
Recurrent Episodes
14%
Rheumatoid Arthritis
79%
Rheumatoid Arthritis Patients
51%
Rituximab
18%
Sectional Analysis
15%
Systemic Lupus Erythematous
14%
Systemic Sclerosis
14%
Triphosphate
16%
Tumor Necrosis Factor-α Blocker
32%
Vaccination
28%
Vaccination Safety
44%
Immunology and Microbiology
Adalimumab
8%
Adoptive Immunity
14%
ANCA Associated Vasculitis
12%
Ankylosing Spondylitis
25%
Arteritis
14%
Arthritis
18%
Biological Product
7%
Disease Classification
29%
Disease-Modifying Antirheumatic Drug
12%
Drug Concentration
8%
Fibroblast
14%
Galectin 3
14%
Giant Cell Arteritis
14%
Glomerulonephritis
7%
Granulocyte Antibody
14%
Hemagglutination Inhibition
10%
Humoral Immunity
15%
Immunogenicity
46%
Inflammatory Arthritis
76%
Inflammatory Bowel Disease
14%
Infliximab
8%
Influenza
39%
Influenza A Virus (H1N1)
18%
Influenza Vaccine
18%
Influenza Virus
14%
Interleukin-6 Receptor
7%
Magnetic Resonance Imaging
19%
Mantoux Test
11%
Methotrexate
26%
Monospecific Antibody
16%
Polysaccharide Vaccine
14%
Population
14%
Prevalence
29%
Psoriatic Arthritis
83%
Rheumatic Disease
29%
Rituximab
18%
Scleroderma
7%
Secretion (Process)
7%
Secukinumab
14%
Synovial Fluid
17%
Systemic Lupus Erythematosus
27%
Systemic Scleroderma
14%
Titer
10%
Tocilizumab
14%
Toll-Like Receptor
14%
Trough Concentration
14%
Tumor Necrosis Factor
46%
Vaccination Policy
74%
Vaccine Efficacy
30%
Vasculitis
14%
Medicine and Dentistry
2009 H1N1 Influenza
14%
Adalimumab
14%
Adenine
14%
ANCA Associated Vasculitis
12%
Ankylosing Hyperostosis
14%
Ankylosing Spondylitis
23%
Arteritis
14%
Biological Marker
14%
Bisphosphonate
14%
Calcium Pyrophosphate
59%
Cellular Immunity
14%
Chondrocyte
14%
Crystal Arthropathy
19%
Diastolic Dysfunction
14%
Dipeptidyl Carboxypeptidase
14%
Disease
66%
Disease Activity
23%
Enthesis
16%
Familial Mediterranean Fever
14%
Giant-Cell Arteritis
14%
Granulocyte Antibody
14%
Hip Joint
14%
Humoral Immunity
11%
Inflammatory Bowel Disease
14%
Influenza A Virus (H1N1)
14%
Influenza Vaccination
14%
Knee Joint
14%
Latent Tuberculosis
14%
Magnetic Resonance Imaging
22%
Mantoux Test
11%
Methotrexate
33%
Operation on Joint
14%
Periodic Fever Syndrome
14%
Peritonitis
14%
Polysaccharide Vaccine
14%
Prednisone
14%
Psoriatic Arthritis
40%
Rheumatic Disease
29%
Rheumatoid Arthritis
66%
Rheumatology
48%
Rituximab
18%
Sacroiliitis
14%
Spondylarthritis
14%
Symptom
22%
Systemic Lupus Erythematosus
24%
Systemic Scleroderma
14%
Takayasu's Arteritis
14%
Tuberculosis
14%
Tumor Necrosis Factor
25%
Vasculitis
14%